BioCentury
ARTICLE | Company News

Management tracks

June 30, 2017 11:00 PM UTC

Cell therapy play BlueRock Therapeutics (Toronto, Ontario) named Emile Nuwaysir president and CEO, and Robert Deans chief technology officer. Nuwaysir was president and COO at Cellular Dynamics International Inc., which Fujifilm Holdings Corp. (Tokyo:4901) acquired in 2015. Deans was CSO at Rubius Therapeutics Inc. (Cambridge, Mass.).

Fertility company OvaScience Inc. (NASDAQ:OVAS) appointed Christopher Kroeger CEO, effective Sept. 1. He was CEO of Cardioxyl Pharmaceuticals Inc. Christophe Couturier will step down as CFO. VP of Finance Jonathan Gillis will assume Couturier's responsibilities. Bristol-Myers Squibb Co. (NYSE:BMY) acquired Cardioxyl in 2015...